Myeloproliferative Disorders: Symptoms, Risk Factors and Treatment Options (Recent Advances in Hematology Research) - Image 1

£75.78

Nova Science Publishers Inc Myeloproliferative Disorders: Symptoms, Risk Factors and Treatment Options (Recent Advances in Hematology Research)

Name: Myeloproliferative Disorders: Symptoms, Risk Factors and Treatment Options (Recent Advances in Hematology Research)
Brand: Nova Science Publishers Inc
Price: 75.78 GBP
Availability: InStock

Diseases & Disorders

This is the most expensive it has ever been. Walk away.

£76 today · previous high £76 · all-time low £74

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 68 days · 68 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 68 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £74 (67 days, 98.5%)

Price range: £74 - £76

Price levels: 2 different prices over 68 days

Description

Myeloproliferative disorders are a group of clonal haematological neoplasms characterised by proliferation of one or more cells of myeloid lineage. They are the result of acquired mutations in the progenitor cell leading to hyper proliferation or neoplastic expansion of more mature forms of myeloid cells. Cells retain their functional ability with some degree of defects and also lead to suppression of normal stem cells. The most common type of Myeloproliferative Neoplasms (MPN) can broadly be classified into BCR ABL positive (Chronic Myelogenous Leukemia) and BCR ABL negative Disorders (Polycythemia Vera PV, Essential Thrombocytosis ET and Primary Myelofibrosis PMF). There are other rare types which have relatively low incidence like chronic neutrophilic leukemia, chronic eosinophilic leukemia, systemic mastocytosis and myeloproliferative neoplasms unclassifiable. These are the indolent type of haematological malignancies associated with marrow hypercellularity and organomegaly, with gradual progression to myelofibrosis or transformation to acute leukemias. During the dormant course of the BCR ABL negative MPN, they are more prone to thrombo-hemorrhagic complications and the treatment strategy is directed mostly to prevent complications. The past decade; therapies for BCR ABL positive disease (CML) have been a milestone achievement in keeping the disease in remission for many years, preventing major complications and halting the progression of the disease. This book discusses the classification, diagnosis and treatment of myeloproliferative diseases and provides insight on the symptoms and risk factors involved in the diseases.

Product Specifications

Brand: Nova Science Publishers Inc
Format: paperback
ASIN: 1633212017
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders
Domain: Amazon UK
Release Date: 01 September 2014
Listed Since: 23 May 2014

Barcode

No barcode data available

Nova Science Publishers Inc Myeloproliferative Disorders: Symptoms, Risk Factors and Treatment Options (Recent Advances in Hematology Research)

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Contemporary Management of Myeloproliferative Neoplasms

Managing Myeloproliferative Neoplasms: A Case-Based Approach

Myeloproliferative Neoplasms: Biology and Therapy (Contemporary Hematology)

Myeloproliferative Neoplasms: Critical Concepts and Management (Hematologic Malignancies)

Myeloproliferative Neoplasms, An Issue of Hematology/Oncology Clinics of North America: Volume 35-2 (The Clinics: Internal Medicine, Volume 35-2)

Veterinary Hematology: A Diagnostic Guide and Color Atlas

Oxford Specialist Handbook: Myeloproliferative Neoplasms (Oxford Specialist Handbooks in Oncology)

American Registry of Pathology Non-Neoplastic Bone Marrow Atlas

Clinical Hematology Atlas

Myeloproliferative Disorders (Hematologic Malignancies)

Desk Reference for Hematology

Bone Marrow Pathology

Preleukemia

Bone Marrow Failure (Pediatric Oncology)

Bone Marrow Diagnosis: An Illustrated Guide

Myeloproliferative Disorders (Hematologic Malignancies)

Non-CML Myeloproliferative Diseases, An Issue of Hematology/Oncology Clinics of North America (Volume 26-5) (The Clinics: Internal Medicine, Volume 26-5)

Myelodysplastic Syndromes: Pathobiology and Clinical Management: 36 (Basic and Clinical Oncology)

Waldenström Macroglobulinemia, An Issue of Hematology/Oncology Clinics of North America: Volume 37-4 (The Clinics: Internal Medicine, Volume 37-4)

Molecular Hematology

MYELOID CELLS: Biology & Regulation, Role in Cancer Progression & Potential Implications for Therapy (Cell Biology Research Progress)

Chronic Lymphocytic Leukemia, An Issue of Hematology/Oncology Clinics of North America: Volume 35-4 (The Clinics: Internal Medicine, Volume 35-4)

Myelodysplastic Syndromes, An Issue of Hematology/Oncology Clinics of North America (Volume 34-2) (The Clinics: Internal Medicine, Volume 34-2)